In an industry defined by constant change, only a few technologies endure.
For aesthetic clinics, enduring performance, clinical confidence and long-term partnership have become increasingly important considerations when investing in new technology. At the centre of this focus sits Solta Medical, a company whose portfolio has helped shape modern energy-based aesthetics for decades.
Recognised globally for its singular commitment to energy-based technology, Solta Medical refines proven platforms over time rather than replacing them. It is an approach grounded in science, clinical evidence and a long-term view of practice growth.
Solta Medical stands behind some of the most trusted and established energy-based platforms in aesthetic medicine, not because it follows trends, but because it sets the standard. Its technologies continue to underpin clinic offerings across prevention, correction and maintenance, supporting positive skin health for patients of all ages and genders while providing clinics with dependable local support and lasting value.
One portfolio, one partner – built to grow with your practice
As clinics look beyond trend-driven investments, there is growing demand for technologies with proven longevity, strong evidence bases and dependable local support.
Solta Medical’s portfolio is intentionally designed to support patients throughout their aesthetic journey, from early prevention and maintenance through to correction, tightening and contouring.
Solta’s systems are designed to work both independently and together, supporting a continuum of care that grows alongside patient needs and clinic ambition. This allows practitioners to build integrated treatment pathways, personalise care and expand services with confidence, while maintaining consistency in training, outcomes and patient experience.
This long-term, ecosystem-based approach reflects the reality of modern aesthetic practice, where patient needs evolve over time and clinics benefit from technologies that can evolve alongside them.
Pioneers of proven premium technology
Rather than rapid device turnover, Solta’s approach centres on the evolution of established platforms. Protocols are continually refined, indications expanded and combination treatment strategies supported to ensure technologies remain clinically relevant as practice needs change.
This allows clinics to build considered treatment portfolios that address prevention, correction and positive ageing, while delivering meaningful outcomes and long-term return on investment.
Solta Medical is the trusted name behind some of the most recognised and clinically established platforms in aesthetic medicine:
Fraxel
The original fractional laser technology in resurfacing and skin renewal, Fraxel is designed to address texture, tone, pigmentation and scarring. A next-generation Fraxel platform is scheduled for release in Australia in late 2026, reinforcing Solta’s commitment to platform evolution.
Thermage
Thermage is a pioneer and global leader in non-invasive skin tightening, with more than five million treatments performed worldwide. Its ability to support collagen maintenance and treat laxity has made it a foundational technology in many practices.
Clear + Brilliant
Trusted for early intervention and long-term skin quality maintenance, Clear + Brilliant offers minimal downtime solutions that appeal to a broad patient demographic.
Global leadership, local commitment
Solta Medical is a global aesthetics company specialising exclusively in energy-based devices, with a long-standing focus on clinical research, regulatory excellence and clinician education.
The global business is guided by experienced leadership, including Jiny Kim, Vice President of Solta Medical, and Pasha Sateri, Vice President of Strategic Marketing.
“The aesthetic medicine industry is constantly evolving, with strong competition and increasing patient expectations. To stay ahead, we focus on three key areas: innovation, market adaptation and clinical excellence.
We will continue to innovate and refine our treatments to meet the growing needs of patients and practitioners. By combining personalisation, effectiveness and wellbeing, we are committed to shaping the future of aesthetic medicine while remaining a leader in the field.”
– Jiny Kim, Senior Vice President, Solta Medical
In Australia, Solta is supported by a dedicated local team led by Alistair McKeon, with a strong emphasis on clinic education, long-term outcomes and ongoing product support. In New Zealand, Solta is exclusively supported by USL Medical, with a focus on emerging and growing clinics.
Why heritage matters in aesthetics
For clinics, technology decisions are rarely short-term. Capital investment, staff training and patient trust all rely on platforms that continue to perform year after year. Solta’s platforms are chosen for their:
- extensive clinical history and global evidence
- consistent, reproducible outcomes
- ongoing protocol evolution rather than rapid replacement
- strong patient recognition and confidence
- long-term return on investment
- ability to grow with your clinic.
As aesthetic medicine continues to mature, the value of heritage, evidence and continuity has never been clearer. Solta Medical’s commitment to proven premium technology, rooted in science, positions it as a stabilising force in a shifting market.
For clinics seeking long-term partnership rather than short-term solutions, Solta offers something increasingly rare: technology designed to endure, supported by an extensive body of clinical evidence and long-term clinical partnership.
For more information, call Solta Medical on (02) 8311 0305 or contact a Solta representative at soltamedical.com.au.
SLT.0016.AU.26
